IRF
IBM Retirement Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-1,886
| Closed | -$308K | – | 26 |
|
2022
Q1 | $308K | Sell |
1,886
-91
| -5% | -$14.9K | 0.04% | 382 |
|
2021
Q4 | $335K | Sell |
1,977
-1,356
| -41% | -$230K | 0.04% | 394 |
|
2021
Q3 | $629K | Buy |
3,333
+17
| +0.5% | +$3.21K | 0.05% | 344 |
|
2021
Q2 | $562K | Sell |
3,316
-613
| -16% | -$104K | 0.04% | 386 |
|
2021
Q1 | $555K | Sell |
3,929
-337
| -8% | -$47.6K | 0.04% | 411 |
|
2020
Q4 | $554K | Sell |
4,266
-136
| -3% | -$17.7K | 0.04% | 415 |
|
2020
Q3 | $641K | Buy |
4,402
+1,075
| +32% | +$157K | 0.06% | 298 |
|
2020
Q2 | $493K | Buy |
3,327
+141
| +4% | +$20.9K | 0.06% | 273 |
|
2020
Q1 | $347K | Buy |
3,186
+983
| +45% | +$107K | 0.06% | 297 |
|
2019
Q4 | $254K | Buy |
+2,203
| New | +$254K | 0.05% | 354 |
|
2018
Q3 | – | Sell |
-2,325
| Closed | -$229K | – | 454 |
|
2018
Q2 | $229K | Sell |
2,325
-252
| -10% | -$24.8K | 0.05% | 425 |
|
2018
Q1 | $307K | Buy |
+2,577
| New | +$307K | 0.06% | 372 |
|
2017
Q1 | – | Sell |
-6,020
| Closed | -$225K | – | 367 |
|
2016
Q4 | $225K | Sell |
6,020
-1,091
| -15% | -$40.8K | 0.01% | 862 |
|
2016
Q3 | $482K | Sell |
7,111
-448
| -6% | -$30.4K | 0.02% | 644 |
|
2016
Q2 | $419K | Buy |
7,559
+76
| +1% | +$4.21K | 0.02% | 729 |
|
2016
Q1 | $470K | Sell |
7,483
-10,545
| -58% | -$662K | 0.02% | 679 |
|
2015
Q4 | $1.7M | Buy |
18,028
+2,174
| +14% | +$205K | 0.03% | 544 |
|
2015
Q3 | $1.27M | Sell |
15,854
-2,287
| -13% | -$184K | 0.03% | 563 |
|
2015
Q2 | $2.18M | Buy |
18,141
+2,422
| +15% | +$290K | 0.04% | 459 |
|
2015
Q1 | $1.64M | Hold |
15,719
| – | – | 0.03% | 567 |
|
2014
Q4 | $1.53M | Buy |
15,719
+1,451
| +10% | +$141K | 0.03% | 576 |
|
2014
Q3 | $1.11M | Sell |
14,268
-1,787
| -11% | -$140K | 0.02% | 644 |
|
2014
Q2 | $1.02M | Buy |
+16,055
| New | +$1.02M | 0.02% | 769 |
|